Carroll J Martin is a director of Catalent, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Esperion Therapeutics, Inc.
24 May 24
4
Catalent, Inc.
31 Oct 23
4
Catalent, Inc.
7 Jul 23
4
Esperion Therapeutics, Inc.
16 Jun 23
4
Esperion Therapeutics, Inc.
11 May 23
4
Catalent, Inc.
31 Oct 22
4
Mallinckrodt plc
21 Jun 22
4
Esperion Therapeutics, Inc.
3 Jun 22
4
Esperion Therapeutics, Inc.
1 Jun 22
3
Esperion Therapeutics, Inc.
1 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 May 24 | ESPR Esperion Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 23,000 | 0.00 | 64,650 |
23 May 24 | ESPR Esperion Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.25 | 32,500 | 73.13 k | 32,500 |
27 Oct 23 | CTLT Catalent | Common Stock | Grant | Acquire A | No | No | 0 | 6,993 | 0.00 | 28,071 |
15 Jun 23 | ESPR Esperion Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 5,150 | 0.00 | 41,650 |
15 Jun 23 | ESPR Esperion Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.37 | 21,000 | 28.77 k | 21,000 |
11 May 23 | ESPR Esperion Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.5714 | 23,091 | 36.29 k | 36,500 |
10 May 23 | ESPR Esperion Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.4919 | 8,409 | 12.55 k | 13,409 |